News

The market expects Fidus Investment (FDUS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Wall Street expects a year-over-year decline in earnings on lower revenues when First Guaranty Bancshares (FGBI) reports results for the quarter ended September 2025. While this widely-known

Fox (FOXA) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a

Wall Street expects a year-over-year decline in earnings on higher revenues when Fortune Brands Innovations (FBIN) reports results for the quarter ended September 2025. While this widely-known

The market expects FirstCash Holdings (FCFS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known

For the quarter ended September 2025, Iridium Communications (IRDM) reported revenue of $226.94 million, up 6.7% over the same period last year. EPS came in at $0.35, compared to $0.21 in the

Bread Financial Holdings (BFH) reported $971 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 1.2%. EPS of $4.02 for the same period compares to

Rogers Communication (RCI) reported $3.88 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 3.3%. EPS of $0.99 for the same period compares to $1.04

Esquire Financial Holdings, Inc. (ESQ) reported $37.57 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 17.7%. EPS of $1.47 for the same period

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 23:

Par Pacific Holdings, Inc. PARR: This energy and infrastructure business has a Zacks

Chewy, Inc.’s CHWY membership program, Chewy+, is emerging as a significant driver of customer engagement and recurring revenues. The program, which offers free shipping, 5% rewards and exclusive

Building a portfolio with stocks that have robust liquidity levels will likely work for investors seeking healthy returns. Liquidity measures a company’s capability to meet its short-term debt

Vertex (VERX) closed the last trading session at $25.86, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Lexeo Therapeutics, Inc. (LXEO) closed the last trading session at $9.23, gaining 41.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Castle Biosciences, Inc. (CSTL) closed the last trading session at $23.74, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Shares of a.k.a. Brands (AKA) have gained 40.6% over the past four weeks to close the last trading session at $13.81, but there could still be a solid upside left in the stock if short-term price

The price trend for United Natural Foods (UNFI) has been bearish lately and the stock has lost 6.2% over the past week. However, the formation of a hammer chart pattern in its last trading session

Shares of Elastic (ESTC) have gained 0.2% over the past four weeks to close the last trading session at $86.07, but there could still be a solid upside left in the stock if short-term price targets

Shares of Allied Gold Corporation (AAUC) have gained 4.1% over the past four weeks to close the last trading session at $17.61, but there could still be a solid upside left in the stock if

Shares of Alto Neuroscience, Inc. (ANRO) have gained 162.9% over the past four weeks to close the last trading session at $10.2, but there could still be a solid upside left in the stock if

A downtrend has been apparent in Allstate (ALL) lately. While the stock has lost 8.3% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed in its last

Shares of Verastem (VSTM) have been struggling lately and have lost 16.4% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock

Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its blockbuster semaglutide-based (GLP-1) drugs — Ozempic (for type II diabetes [T2D]) and

United Rentals, Inc. URI witnessed a 5.2% fall in its share price during the after-hours trading session yesterday, following the release of the third-quarter 2025 results. The company’s earnings

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service